ici 204,219 has been researched along with Cancer of Kidney in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intriguingly, long-term use of zafirlukast decreases cancer risk and leukotriene receptor antagonists inhibit tumor growth, but the mechanisms still remain unexplored." | 1.72 | Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells. ( Smith, S; van Wijk, SJL; Wolf, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolf, C | 1 |
| Smith, S | 1 |
| van Wijk, SJL | 1 |
1 other study available for ici 204,219 and Cancer of Kidney
| Article | Year |
|---|---|
Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells.
Topics: Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; G | 2022 |